Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

Paydas, SEMRA

doi:10.1093/annonc/mdw193

Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

Paydas S.

ANNALS OF ONCOLOGY, vol.27, no.8, pp.1650-1651, 2016 (Journal Indexed in SCI)

Publication Type: Article / Letter
Volume: 27 Issue: 8
Publication Date: 2016
Doi Number: 10.1093/annonc/mdw193
Title of Journal : ANNALS OF ONCOLOGY
Page Numbers: pp.1650-1651

Abstract

Granulomatous reaction developing after immunotherapy must not be named as sarcoidosis, post-immunotherapy granulomatous reaction is more approprite in cases receiving immunotherapy.